Due to the pandemic, this year’s meeting of the ANDEMIA network could only take place online and in a shortened form. On 24 November 2020, the project partners from the four African partner countries met online to digitally exchange information about project progress despite the corona impairments and plans for the future of the project. The respective syndromes were discussed like in previous years in plenary as well as subgroup discussions.
Besides the ANDEMIA activities project members also discussed the national SARS-CoV 2 activities they are involved in.
Even despite the shortness of this year’s meeting we had very fruitful discussions and hope to meet again in person in 2021.
Stay healthy!

From 22.09. – 11.10. 2020 Andreas Sachse (P3/RKI) held a 3-week laboratory training course on molecular SARS-CoV-2 diagnostics, especially on mobile sequencing using MinION (Oxford Nanopore Technology) at the University Hospital CHU Bouaké in the Ivory Coast in order to provide specific support for Ivorian colleagues in the current pandemic.

During the stay Mr. Sachse sequenced together with the Ivorian scientist Etile Anoh a total of 208 samples, mainly from the national Coronavirus Surveillance. During Mr. Sachse’s stay, 64 sequences have been generated so far and these are the first Ivorian SARS-CoV-2 sequence data made available to the public via GISAID. GISAID is an online platform that allows for the rapid international exchange of genomic data, including SARS-CoV-2. At the same time, 7 SARS-CoV-2 full genomes of patients of the BMBF-funded ANDEMIA study from the Democratic Republic of Congo (report September 2020) could be published on the same platform.

In order to support the Congolese colleagues in the current pandemic, a laboratory training in molecular SARS-CoV-2 diagnostics and serology took place at the INRB in Kinshasa.

During a 3-week stay (05.-28.08.2020), Caroline Röthemeier from RKI, Germany and the Congolese ANDEMIA team examined sample material that had been routinely collected from ANDEMIA participants since December 2019. RNA was extracted from over 600 nasal/pharyngeal swabs from patients with acute respiratory symptoms and tested for SARS-CoV-2. In addition, 480 serum samples were serologically tested for the presence of long-term antibodies (IgG) against SARS-CoV-2. Seropositive samples will now be tested by neutralization test at the RKI.

The local staff trained by Ms. Röthemeier is now also responsible for the analysis within a SARS-CoV-2 antibody study among health care workers and their families in Kinshasa. This study is carried out in cooperation between the RKI, the INRB/Kinshasa, the ITM/Antwerp and the IRD/Montpellier.

This training was financially and organizationally supported by the GHPP project ARGOS and ZIG3/RKI respectively.

SARS-CoV-2 is widely spreading throughout the African continent, and with a focus on also acute respiratory disease, ANDEMIA is highly engaged in supporting our African partner countries in responding to the pandemic.

We therefore included SARS-CoV-2 PCR in our routine testing panel for all ANDEMIA patients (co-funded by BMBF through the sub-project ANCOS), implemented mobile sequencing techniques in order to investigate infection chains, and started a pilot serological survey to draw inference on the level of exposure of local populations to the virus.

Adding COVID-19 to the research program of ANDEMIA will aid to close important knowledge gaps in the understanding of COVID-19 disease dynamics and epidemiology, provides a platform for long-term monitoring of COVID-19 pneumonia, and most importantly practically assists in national COVID-19 control efforts, which is of utmost importance.

From the 24.02. to 08.03.2020 three members of the German ANDEMIA team from RKI spent two weeks at the partner site “Centre Muraz” and “Centre Hospitalier Universitaire Souro Sanou” at Bobo-Dioulasso in Burkina Faso.

As the previous stay in Côte d’Ivoire the main focus of the trip was retraining of enrolment staff and quality assurance in laboratory practices. This included pre-analytics such as proper blood sampling procedures and avoiding contamination in blood culture (training video), as well as individual training and reassessment of laboratory practices in both molecular and bacteriological testing. On the molecular testing side, the validation of results was re-evaluated and focused on. On the bacteriological side, the team from RKI emphasized the use of API galleries for bacteria identification with an introduction to the APIweb system. Lastly, several meetings for the start of enrolment of healthy controls were organized to discuss last organizational questions and to successfully launch enrolment in Burkina Faso.

From the 14th of January to the 13th of February 2020 Essia Belarbi and Paul Pitzinger from the german ANDEMIA team visited all study sites in Côte d’Ivoire to re-train laboratory staff in bacteriological and molecular laboratory processes and to implement the enrolment of healthy controls at the different sites.

Health care workers received a refresher training in aseptic blood sampling in order to reduce contamination rates in blood culture, which was supported by a short training video, provided by ANDEMIA and the ITM Antwerp. This video can be accessed freely on the internet here and should be used by the partners to either train new personnel or to remind established health care workers on the proper techniques.

To further improve the quality of bacteriological results biologists and technicians of the bacteriology labs in Bouaké and Guiglo were trained in the use of the API®(Analytical Profile Index) system.  Lastly, the implementation of healthy control enrolment was presented to all study sites. As this phase is crucial for the further analysis and interpretation of results, the protocol was discussed in detail to make sure that every site is familiar with procedures and can start enrolment.

From 28th to 31st of January 2020 members of the ANDEMIA team attended the “Research Network for Health Innovations in Sub Saharan Africa mid-term meeting” in Accra, Ghana. During several workshops and panel discussions African and German scientists from all of the five networks came together to discuss global health questions and to exchange experiences regarding cross-project topics. Project specific issues were discussed in internal network meetings

The fourth ANDEMIA network meeting took place in Berlin from 18th to 22nd November 2019. Project partners from the four African partner countries met at the Robert Koch Institute to discuss progress, problems and plans for the future of ANDEMIA. Of course, employees of the BMG-funded GHPP projects TRICE and ARGOS, which are closely linked to ANDEMIA, were also invited to exchange information with joint project partners. One of the main objectives of this year’s meeting was to plan targeted data analyses and to develop a publication plan.

In the run-up to our network meeting, three workshops for ANDEMIA Master and PhD students, as well as project staff of ARGOS and TRICE, took place:
A workshop on “Proposal writing”, aimed at enabling students to write structured project proposals. In the workshop “Data reporting”, the participants were instructed in compiling and evaluating data from the ANDEMIA database. In the third workshop the participants gained insight into mobile sequencing using MinION technology, which is to be established in the partner countries as an additional diagnostic tool.

A two-week workshop was held at the Centre Hospitalier Universitaire in Bouaké from 15 to 28 June 2019 in collaboration with Prof. Chantal Akoua-Koffi to improve the quality of data on bacterial identification and antimicrobial resistance (AMR) as well as the general epidemiological collection and analysis of data. The training was aimed at study team members from ANDEMIA and the BMG funded GHPP project ARGOS. Various members of the Cote d’Ivoire study team participated in the workshop as well as two participants from Burkina Faso and the Democratic Republic of Congo who travelled to take part in the meeting. Two participants from RKI, Germany also helped to facilitate the workshop, which was sponsored by funds from the Global Health Protection Programme of the German Ministry of Health.

Bacteriology and AMR testing SOPs were reviewed together in detail, revised and harmonised according to international standards and laboratory practice in each of the study countries. A laboratory risk evaluation was conducted and the results were used to create a quality control plan with concrete objectives, timing and criteria. A training was given on WHONET and a template was practically developed to record and analyse ongoing results of the quality control activities. Lastly, a plan was made for next steps in the following six months to improve the exchange on results of bacteriology and AMR testing in the network.

To improve overall quality of epidemiological data collection, a new reporting process was discussed with all countries including a validation process of all past data and ongoing weekly data management reports to more effectively detect and correct errors in data collection and management. Future possibilities for regular  teleconferences or online training were also discussed.

A course in „Advanced Epidemiology and Statistics“ was held at the National Institute for Communicable Diseases (NICD) in Johannesburg from the 7th to the 23rd of May 2019. The course was taught by Dr. Matthias Borchert (RKI Berlin). Overall 14 participants from DRC, Burkina Faso, Côte d’Ivoire, Sierra Leone, Guinea and South-Africa took part in the 15-day course to learn and apply hands-on advanced statistical methods used in epidemiology, including regression analysis, advanced data management and analysis of case-control studies. The contents were conveyed during lectures, interactive and group sessions as well as an assignment and written examination component.

Directly afterwards, from 27th May until 6th June 2019 a second workshop on the topic „Molecular Biology“ was given at NICD, organised by our colleagues from UP and NICD. In total 9 candidates from all 4 ANDEMIA countries participated in the workshop.
During a hands-on training the participants processed human clinical specimen of ANDEMIA patients of South Africa and isolated strains or controls. The scope of the training was to improve skills in the molecular techniques for each of the 3 ANDEMIA syndromes, such as multiplex real-time PCR and application of a macroarray, as well as good laboratory practice, interpretation of results, data storage and quality control.